Kither Biotech announces publication of new data in Science Translational Medicine
Kither Biotech announces publication of new data in Science Translational Medicine Data support the use of Kither Biotech’s lead asset, KIT2014, in obstructive airway diseases KIT2014 demonstrated a triple mechanism of action in reversing disease pathogenesis: enhancing functionality of CFTR channels and reducing bronchoconstriction and inflammation Adds to evidence supporting